Pfizer launches pipeline website
Executive Summary
Pfizer's pipeline website, 1www.pfizer.com/pipeline, goes live Dec. 20. The site, which the firm first disclosed during a November investor meeting, includes clinical programs from Phase I to late-stage and recently approved compounds. The website is part of an ongoing effort at Pfizer under CEO Jeffrey Kindler to be more transparent to investors. Pfizer expects its Phase III portfolio to triple by 2009 (2"The Pink Sheet" Dec. 4, 2006, p. 5)...
You may also be interested in...
Pfizer R&D Emphasizes M&A; Deal Structure, Integration To Be More Flexible
Pfizer anticipates that one-third of the six new products the company expects to launch annually beginning in 2011 will derive from enhanced external sourcing efforts
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.